Literatur:
- 1
Bardou M, Toubouti Y, Benhaberou-Brun D, Rahme A.
High dose proton pump inhibition decrease both rebleeding and Letality in high risk
patients with acute peptic ulcer bleeding. A series of meta-analyses.
Gastroenterology.
2003;
123
625
- 2
Barkun A, Bardou M, Marshall J K. Nonvariceal Upper GI Bleeding Consensus Conference
Group .
Consensus recommendations for managing patients with nonvariceal upper gastrointestinal
bleeding.
Ann Intern Med.
2003;
139
843-857
- 3
Barkun A, Racz I, van Rensburg C. et al .
Prevention of peptic ulcer rebleeding using continuous Infusion of Pantoprazole vs.
Ranitidine: A multicenter, multinational, randomized, double-blind, parallel group
comparison.
Gastrointest Endosc.
2004;
59
609
- 4
Barkun A N, Herba K, Adam V, Kennedy W, Fallone C A, Bardou M.
High-dose intravenous proton pump inhibition following endoscopic therapy in the acute
management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness
analysis.
Aliment Pharmacol Ther.
2004;
19
591-600
- 5
Berstad A.
Does profound acid inhibition improve haemostasis in peptic ulcer bleeding?.
Scan J Gastroenterol.
1997;
32
376-382
- 6
Calvet X, Vergara M, Brullet E, Gisbert J P, Campo R.
Addition of a second endoscopic treatment following epinephrine injection improves
outcome in high-risk bleeding ulcers.
Gastroenterology.
2004;
126
441-50
- 7
Collins R, Langman M.
Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage.
N Engl J Med.
1985;
313
660-666
- 8
Daneshmend T K, Hawkey C J, Langman M JS, Logan R FA, Long R G, Walt R P.
Omeprazole versus Placebo for acute upper gastrointestinal bleeding: a randomised
double blind controlled trial.
BMJ.
1992;
304
143-147
- 9
Ell C, Hagenmüller F, Schmitt W, Riemann J F, Hahn E G, Hohenberger W.
Multicenter prospective study of the current status of treatment for bleeding ulcer
in Germany.
Dtsch Med Wochenschr.
1995;
120
3-9
- 10
Gagnon Y M, Levy A R, Eloubeidi M A, Arguedas M R, Rioux K P, Enns R A.
Cost implications of administering intravenous proton pump inhibitors to all patients
presenting to the emergency department with peptic ulcer bleeding.
Value in health.
2003;
6
457-465
- 11
Gisbert J P, Gonzalez L, Calvet X, Roque M, Gabriel R, Pajares J M.
Proton pump inhibitors versus H2-antagonists: a meta analysis of their efficacy in
treating bleeding peptic ulcer.
Aliment Pharmacol Ther.
2001;
15
917-926
- 12
Goldstein J A.
Clinical relevance of genetic polymorphisms in the human CYP2C subfamily.
Br J Clin Pharmacol.
2001;
52
349-355
- 13
Goletti O, Sidoti F, Lippolis P V, De Negri F, Cavina E.
Omeprazole versus Ranitidine plus Somatostatin the treatment of severe gastroduodenal
bleeding: a prospective randomised controlled trial.
Ital J Gastroenterol.
1994;
26
72-74
- 14
Green F J, Kaplan M M, Curtis L E, Levine P H.
Effect of acid and pepsin on blood aggregation and platelet aggregation. A possible
contributor to prolonged gastroduodenal haemorrhage.
Gastroenterology.
1978;
74
38-43
- 15
Hartmann D, Schilling D, Riemann J F.
Effect of intravenous application of Omeprazole 20 mg vs Omeprazole 40 mg vs Pantoprazole
40 mg on 24 hour intragastric pH in male healthy adults.
Gastroenterology.
2004;
126
(Suppl 2)
443
- 16
Hasselgren G, Lind T, Lundell L. et al .
Continuous intravenous infusion of Omeprazole in elderly patients with peptic ulcer
bleeding: results of a Placebo controlled multicenter study.
Scand J Gastroenterol.
1997;
32
328-333
- 17
Jensen D M.
Treatment of patients at high risk for recurrent bleeding from a peptic ulcer.
Ann Intern Med.
2003;
139
294-295
- 18
Jung H K, Son H Y, Jung S A. et al .
Comparison of oral Omeprazole and endoscopic ethanol injection therapy for prevention
of recurrent bleeding from peptic ulcers with nonbleeding visible vessels or fresh
adherent clots.
Am J Gastroenterol.
2002;
97
1736-1740
- 19
Kaviani M J, Hashemi M R, Kazemifar A R. et al .
Effect of oral Omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective,
double-blind, randomized, clinical trial.
Aliment Pharmacol Ther.
2003;
17
211-216
- 20
Khuroo M S, Yattoo G N, Javid G.
A comparison of Omeprazole and Placebo for bleeding peptic ulcer.
N Engl J Med.
1997;
336
1054-1058
- 21
Kohler B, Maier M, Benz C, Riemann J F.
Acute ulcer bleeding. A prospective randomized trial to compare Doppler and Forrest
classifiaction in endoscopic diagnosis and therapy.
Dig Dis Sci.
1997;
42
1370-1374
- 22
Labenz J, Peitz U, Leusing C, Tillenburg B, Blum A L, Boersch G.
Efficacy of primed infusion with high dose Ranitidine and Omeprazole to maintain high
intragastric pH in patients with peptic ulcer bleeding: a prospective randomized controlled
study.
Gut.
1997;
40
36-41
- 23
Laterre P F, Horsmans Y.
Intravenous Omeprazole in critically ill patients: A randomized, crossover study comparing
40 with 80 mg plus 8 mg/hour on intragsatric pH.
Crit Care Med.
2001;
29
1931-1935
- 24
Lau J YW, Sung J JY, Lee K KC. et al .
Intravenous Omeprazole on recurrent bleeding after endoscopic treatment of bleeding
peptic ulcers.
N Engl Med.
2000;
343
310-316
- 25
Lee K KC, You J HS, Wong I CK. et al .
Cost-effectiveness analysis of high-dose Omeprazole infusion as adjuvant therapy to
endoscopic treatment of bleeding peptic ulcer.
Gastrointest Endosc.
2003;
57
160-164
- 26
Leontiadis G , Sharma V K, Howden C W.
Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer
bleeding.
BMJ.
2005;
doi: 10.1136/bmj.38356.641134.8F
- 27
Levine J E, Leontiadis G I, Sharma V K, Howden C W.
Meta-analysis the efficacy of intravenous H2 receptor antagonists in bleeding peptic
ulcer.
Aliment Pharmacol Ther.
2002;
16
1137-1142
- 28
Lin H j, Lo W C, Lee F Y, Perng C L, Tseng G Y.
A prospective randomized comparative trial showing that Omeprazole prevents rebleeding
in patients with bleeding peptic ulcer after successful endoscopic therapy.
Arch Intern Med.
1998;
158
54-58
- 29
Mössner J, Caca K.
Standards bei der oberen gastrointestinalen Ulkusblutung.
Dtsch Med Wochenschr.
2003;
128
64-68
- 30
Netzer P, Gaia C, Sandoz M. et al .
Effect of repeated injection and continuous infusion of Omeprazole and Ranitidine
on intragastric pH over 72 hours.
Am J Gastroenterol.
1999;
94
351-357
- 31
Non-variceal upper gastrointestinal haemorrhage: guidelines British Society of Gastroenterology
Endoscopy Commitee.
Gut.
2002;
51
(Suppl IV)
1-6
- 32
Rensburg C J, Hartmann M, Thorpe A. et al .
Intragsatric pH during continuous infusion with Pantoprazole in patients with bleeding
peptic ulcer.
Am J Gastroenterol.
2003;
98
2635-2641
- 33
Rockall T A, Logan R F, Devlin H B, Northfield T C.
Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United
Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal
Haemorrhage.
BMJ.
1995;
311
222-226
- 34
Rockall T A, Logan R F, Devlin H B, Northfield T C.
Risk assessment after acute upper gastrointestinal haemorrhage.
Gut.
1996;
38
316-321
- 35
Sachs G, Shin J M.
The basis of differentiation of PPIs.
Drugs Today.
2004;
40
(Suppl)
9-14
- 36
Schulz H J, Kinzel F.
Standards in der Diagnostik und Therapie der oberen gastrointestinalen Blutung.
Dtsch Med Wochenschr.
2004;
129
114-116
- 37
Selby N M, Kubba A K, Hawkey C J.
Acid suppression in peptic ulcer haemorrhage: a meta-analysis.
Aliment Pharmacol Ther.
2000;
14
1119-1126
- 38
Sung J J, Chan F K, Lau J Y.
The effect of endoscopic therapy in patients receiving Omeprazole for bleeding ulcers
with nonbleeding.
Ann Intern Med.
2003;
139
237-243
- 39
Udd M, Miettinen P, Palmu A. et al .
Regular-dose versus high-dose Omeprazole in peptic ulcer bleeding: a prospective randomized
double-blind study.
Scand J Gastroenterol.
2001;
36
1332-1338
- 40
Walt R P, Correll J, Mann S G, Freemantle N P, Langmann M J.
Continuos intravenous famotidine for haemorrhage from peptic ulcer.
Lancet.
1992;
340
1058-1062
- 41
Wilder Smith C, Boudarov P, Hallerbaeck B, Nilsson-Pieschl C, Ahlbom H, Röhss K.
Esomeprazole 40 mg intravenous provides faster and more effective acid control than
Pantoprazol 40 mg intravenous after first dose and five days.
Gut.
2003;
52
(Suppl VI)
129
- 42
Zed P J, Loewen P S, Slavik R S, Marra C A.
Meta-analysis of proton pump inhibitors in treatment of bleeding peptic ulcers.
Ann Pharmacother.
2001;
35
1528-1534
Priv.-Doz. Dr. D. Schilling
Medizinische Klinik C, Klinikum der Stadt Ludwigshafen gGmbH
Bremserstr. 79
67063 Ludwigshafen /Rhein
Telefon: 0621/5034161
Fax: 0621/5034162
eMail: Schillid@klilu.de
